BURLINGTON, Mass.--(BUSINESS WIRE)--ConforMIS, Inc., a privately held orthopedics company that develops and commercializes minimally invasive medical devices for the treatment of osteoarthritis and joint damage, today announced the launch of the first and only patient-specific bicompartmental knee resurfacing implant on the market. The iDuo™ is the third in the line of minimally invasive, patient-specific implants ConforMIS has developed for the treatment of osteoarthritis of the knee, the most common reason for knee replacement surgery.
